|
Volumn 24, Issue 6, 2004, Pages 1427-1434
|
Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA GALACTOSIDASE;
CANCER VACCINE;
INTERLEUKIN 12;
MONOCLONAL ANTIBODY;
PEPTIDE FRAGMENT;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
ARTICLE;
BONE MARROW;
CD8+ T LYMPHOCYTE;
COMPARATIVE STUDY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY TEST;
DBA MOUSE;
FEMALE;
IMMUNOLOGICAL MEMORY;
IMMUNOLOGY;
INTRAPERITONEAL DRUG ADMINISTRATION;
LACTOSE OPERON;
MAJOR HISTOCOMPATIBILITY COMPLEX;
METABOLISM;
MOUSE;
PERITONEAL CAVITY;
SUBCUTANEOUS DRUG ADMINISTRATION;
T CELL LYMPHOMA;
VACCINATION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BETA-GALACTOSIDASE;
BONE MARROW;
CANCER VACCINES;
CD8-POSITIVE T-LYMPHOCYTES;
CYTOTOXICITY TESTS, IMMUNOLOGIC;
FEMALE;
IMMUNOLOGIC MEMORY;
INJECTIONS, INTRAPERITONEAL;
INJECTIONS, SUBCUTANEOUS;
INTERLEUKIN-12;
LAC OPERON;
LYMPHOMA, T-CELL;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MICE;
MICE, INBRED DBA;
PEPTIDE FRAGMENTS;
PERITONEAL CAVITY;
T-LYMPHOCYTES, CYTOTOXIC;
TUMOR NECROSIS FACTOR-ALPHA;
VACCINATION;
|
EID: 16544380846
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (0)
|